<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04590313</url>
  </required_header>
  <id_info>
    <org_study_id>39§/30.9.2020</org_study_id>
    <nct_id>NCT04590313</nct_id>
  </id_info>
  <brief_title>Treatment of Hallux Rigidus</brief_title>
  <acronym>HARD</acronym>
  <official_title>Treatment of Hallux Rigidus (HARD): A Prospective, Randomised, Controlled Trial of Arthrodesis Versus Watchful Waiting in the Treatment of Hallux Rigidus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital District of Helsinki and Uusimaa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital District of Helsinki and Uusimaa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised, controlled trial will be performed by allocating 40 years or older patients&#xD;
      with symptomatic hallux rigidus to arthrodesis or watchful waiting group in a ratio of 1:1.&#xD;
      Our primary outcome will be pain during walking, assessed by the 0-10 Numeric Rating Scale&#xD;
      (NRS) at one year after randomisation. Our secondary outcomes will be pain in rest (NRS),&#xD;
      physical function (MOXFQ), patient satisfaction in terms of Patient-accepted Symptom State&#xD;
      (PASS), health-related quality of life (EQ-5D-5L), activity level (The Foot and Ankle Ability&#xD;
      Measure Sports subscale), use of analgesics or orthoses and rate of complications. Our null&#xD;
      hypothesis is that there will be no difference between arthrodesis and watchful waiting in&#xD;
      treatment of hallux rigidus. Our primary analysis will be done using intention-to-treat&#xD;
      principle.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2030</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomised, controlled trial will be performed by allocating 40 years or older patients with symptomatic hallux rigidus to arthrodesis or watchful waiting group in a ratio of 1:1.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>To avoid biased interpretation of the trial data, blinded data interpretation will be used in the reporting of the results of this trial (70). Before accessing the primary outcome data, the writing committee will record a 'Background assumptions' document containing our definition of MID of the outcome measures, and a brief summary of the key statistical analysis used in the evaluation of the outcome data. The document will be signed by the members of the writing committee and published as an appendix to the primary publication.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain during walking in Numerical Rating Scale (NRS)</measure>
    <time_frame>1 year after randomisation</time_frame>
    <description>scale 0-10; 0=no pain, 10=worst pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain during rest in Numerical Rating Scale (NRS)</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>scale 0-10; 0=no pain, 10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during walking in Numerical Rating Scale (NRS)</measure>
    <time_frame>6 months, 2 years, 5 years</time_frame>
    <description>scale 0-10; 0=no pain, 10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Related Outcome</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>MOXFQ-score, Scale 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported quality of life</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>EQ-5D-5L, Scale 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>Number of minor and major adversary effects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Acceptable Symptom State</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>Percentage of patients with acceptable symptom state (PASS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients physical activity</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>FAAM Sports Subscale, Scale 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of analgesics and orthoses</measure>
    <time_frame>6 months, 1year, 2 years, 5 years</time_frame>
    <description>The use of analgesics: 1) no use of analgesics or less frequent than weekly, 2) weekly use of analgesics, 3) daily use of NSAIDS or paracetamol, 4) daily use of opioids.&#xD;
The use of orthoses: yes/no</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hallux Rigidus</condition>
  <arm_group>
    <arm_group_label>Arthrodesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>MTPJ I Arthrodesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Watchful waiting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention, patient information leaflet</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthrodesis</intervention_name>
    <description>MTPJ I arthrodesis</description>
    <arm_group_label>Arthrodesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 40 years or over&#xD;
&#xD;
          -  Diagnosis of hallux rigidus: Persistent pain on movement of the first MTPJ AND&#xD;
             Osteoarthritic first MTPJ in plain X-rays&#xD;
&#xD;
          -  Duration of symptoms ≥1 year&#xD;
&#xD;
          -  Pain-NRS during walking of 4 or more on a scale 0-10 (higher is worse)&#xD;
&#xD;
          -  No substantial pain in other joints of the foot in clinical examination&#xD;
&#xD;
          -  Willingness to accept both treatment options&#xD;
&#xD;
          -  Ability to understand trial information and answer outcome assessments in Finnish&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA* physical status classification level III or higher&#xD;
&#xD;
          -  Patients with weak co-operation (dementia, schizophrenia, etc.)&#xD;
&#xD;
          -  Patients with neuropathy, i.e. unable to feel 10g monofilament pressure in less than 8&#xD;
             out of 10 standard testing sites&#xD;
&#xD;
          -  Active bacterial infection or ulcer of the lower limb&#xD;
&#xD;
          -  Diabetes mellitus with insulin treatment&#xD;
&#xD;
          -  Diabetes mellitus and GHb-A1C &gt;64 mmol/mol (regardless of treatment)&#xD;
&#xD;
          -  History of rheumatoid arthritis, gout or other inflammatory arthritis of the foot&#xD;
&#xD;
          -  Hallux valgus angle &gt;15° in weight-bearing X-ray&#xD;
&#xD;
          -  Hallux varus in weight-bearing X-ray&#xD;
&#xD;
          -  Large bone cysts in X-ray probably requiring bone grafting in surgery&#xD;
&#xD;
          -  Pain in passive manipulation of ipsilateral first toe IP joint&#xD;
&#xD;
          -  Patients with severe circulatory disorder of the lower limb: absence of palpable&#xD;
             pulses in the foot (both dorsalis pedis artery and tibialis posterior artery)&#xD;
&#xD;
          -  History of surgery of the foot in question&#xD;
&#xD;
          -  Neuropathic pain of the foot in question (i.e., use of neuropathic analgesics)&#xD;
&#xD;
          -  Activity limiting symptoms from an earlier fracture or ligament injury of the foot&#xD;
&#xD;
          -  Patient is not willing to accept the operation within the planned time limits (3 to 12&#xD;
             weeks post-randomisation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jussi Repo, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital District of Helsinki and Uusimaa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mikko Miettinen, M.D.</last_name>
    <phone>+35894711</phone>
    <email>mikko.miettinen@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jussi Repo, M.D., Ph.D.</last_name>
    <phone>+35894711</phone>
    <email>mrjussirepo@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikko Miettinen, M.D.</last_name>
      <phone>+35894711</phone>
      <email>mikko.miettinen@hus.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital District of Helsinki and Uusimaa</investigator_affiliation>
    <investigator_full_name>Mikko Miettinen</investigator_full_name>
    <investigator_title>Consultant orthopaedic surgeon, M.D.</investigator_title>
  </responsible_party>
  <keyword>surgery</keyword>
  <keyword>foot</keyword>
  <keyword>hallux</keyword>
  <keyword>hallux rigidus</keyword>
  <keyword>arthrodesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hallux Rigidus</mesh_term>
    <mesh_term>Hallux Limitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

